Results 61 to 70 of about 1,423 (197)

A rare presentation of atypical demyelination:tumefactive multiple sclerosis causing Gerstmann’s syndrome [PDF]

, 2014
Background: Tumefactive demyelinating lesions are a rare manifestation of multiple sclerosis (MS). Differential diagnosis of such space occupying lesions may not be straightforward and sometimes necessitate brain biopsy.
Gnanapavan, Sharmilee, Gnanasambandam, Sakthivel, Jaunmuktane, Zane, Pegoretti Baruteau, Kelly, Schmierer, Klaus   +4 more
core   +4 more sources

Marburg variant of multiple sclerosis; a diagnostic and therapeutic challenge [PDF]

, 2015
Marburg variant of multiple sclerosis (MS) is a highly aggressive, fulminant demyelinating disease with very high morbidity and mortality. Early diagnosis and aggressive management is vital to limit severe disability and improve the outcome. We present a
Imtiaz, Sadia, MD, Arsalan Ahmad, Siddiqui, Maimoona   +2 more
core   +1 more source

Atypical inflammatory demyelinating syndromes of the CNS [PDF]

, 2016
Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis.
Barnett, Michael H., Hardy, Todd A., Lucchinetti, Claudia F., Palace, Jacqueline, Reddel, Stephen W., Weinshenker, Brian G.   +5 more
core   +2 more sources

Longitudinal Brain Atrophy Patterns in Early MOG‐Antibody Associated Disease and Relapsing Multiple Sclerosis

European Journal of Neurology, Volume 32, Issue 11, November 2025.
ABSTRACT Background Myelin oligodendrocyte glycoprotein antibody‐associated disease can manifest as a relapsing or monophasic condition. Although several MRI studies have shown evident gray and white matter atrophy compared to healthy controls, little is known about regional brain volume dynamics in myelin oligodendrocyte glycoprotein antibody ...
Theodoros Ladopoulos, David Bratek, Carolin Schwake, Ann‐Kathrin Kogel, Barbara Bellenberg, Britta Krieger, Zainab Abbas, Ralf Gold, Carsten Lukas, Ilya Ayzenberg, Ruth Schneider   +10 more
wiley   +1 more source

Clinical and Radiographic Spectrum of Pathologically Confirmed Tumefactive Multiple Sclerosis [PDF]

, 2008
Atypical imaging features of multiple sclerosis lesions include size \u3e2 cm, mass effect, oedema and/or ring enhancement. This constellation is often referred to as \u27tumefactive multiple sclerosis\u27.
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, F. Konig, C. Giannini, H. Lassmann, L. Linbo, S. J. Pittock, W. Bruck, Al-Bunyan, Alderson, Annesley-Williams, Annunziata, Atlas, Avasarala, Barkhof, Barkhof, Bolay, Brinar, Butteriss, Charil, Chen, Confavreux, Dagher, Di Patre, Enzinger, Ernst, Fazekas, Fazekas, Frederiksen, Friedman, Giang, Gomori, Gutling, Haimes, Hart, Hawkins, Hayashi, Hershey, Hunter, I  iguez, Iwamoto, Noseworthy, Johnson, Kalyan-Raman, Kahana, Karaarslan, Keegan, Kepes, Khoshyomn, Kim, Kotil, Kurihara, Lublin, Lucchinetti, Maranh  o-Filho, Martinelli, Masdeu, Masdeu, Mayr, McAdam, McDonald, Metafratzi, Miller, Miller, Morimoto, Morioka, Nesbit, Niebler, Nyquist, O'Brien, OLMOS-LAU, Omuro, Paley, Paolino, Paty, Perneger, Peterson, Pittock, Poser, Poser, Rolak, Sagar, Schwartz, Sharief, Stendahl-Brodin, Sugita, Tumani, Weinshenker, Wingerchuk, Wurm, Yapici, Youl, Zagzag, Zeman   +101 more
core   +3 more sources

Tumefactive multiple sclerosis: the lethal chameleon

European Journal of Case Reports in Internal Medicine
Tumefactive multiple sclerosis (TMS) is a rare variant of multiple sclerosis that presents with a large demyelinating lesion in the central nervous system, accompanied by peripheral ring-like enhancement, perilesional oedema and mass effect.
Ana Carolina Monteiro, Tomás França de Santana, Carolina Chumbo, Catarina Negrão, Teresa Valido, Filipa Figueiredo, Clara Matos   +6 more
doaj   +1 more source

Neuroimaging Spectrum in COVID-19 Infection: A Single-Center Experience

Indian Journal of Radiology and Imaging, 2023
Background and Purpose The ongoing coronavirus disease 2019 (COVID-19) pandemic is a multisystemic disease and involvement of the nervous system is well established.
Sarbesh Tiwari, Pawan Kumar Garg, Samhita Panda, Aanchal Gupta, Adarsh Hegde, Deepak Kumar, Daisy Khera, Pradeep Kumar Bhatia, Mayank Garg, Taruna Yadav   +9 more
doaj   +1 more source

Neuromyelitis Optica Mimicking Multiple Sclerosis: A Case Report and a Comprehensive Review of the Literature

Clinical Case Reports, Volume 13, Issue 10, October 2025.
Post‐gadolinium enhancement of the spinal cord seen in NMO. ABSTRACT Neuromyelitis optica spectrum disorder (NMOSD) may mimic other neurological conditions, including multiple sclerosis (MS). We report a 25‐year‐old woman with hypothyroidism and depression who presented with progressive quadriparesis.
Sunil Thatal, Susmin Karki, Asmita Parajuli, Sweta Bhandari, Bibek K. C., Dibasha Adhikari, Navin Kumar Sah   +6 more
wiley   +1 more source

Tumefactive Demyelination Lesions: Report on Three Cases

Acta Neurologica Taiwanica
Purpose: Tumefactive demyelination (TD) lesion and its subtype Balo’s concentric sclerosis (BCS), are rare manifestations of central nervous system demyelinating disease.
Chi-Ju Lin, Shih-Chieh Lin, Kai-Wei Yu, Wen-Yu Ou Yang, Yi-Chung Lee, Yi-Chu Liao   +5 more
doaj   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, Volume 12, Issue 8, Page 1566-1574, August 2025.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source